Jun 13, 2024 bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
May 3, 2024 bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
May 3, 2024 bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
May 3, 2024 CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024